The epidemiology of non-polio enteroviruses: Recent advances and outstanding questions

Current Opinion in Infectious Diseases

Volumn 28, Issue 5, 2015, Pages 479-487

  Pons Salort, Margarita ^a   Parker, Edward P K ^a   Grassly, Nicholas C ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

enterovirus; epidemiology; hand foot and mouth disease; outbreak; vaccine

Indexed keywords

ACUTE HEMORRHAGIC CONJUNCTIVITIS; ANTIGENICITY; ENTEROVIRUS INFECTION; EPIDEMIC; EYE DISEASE; GENE SEQUENCE; GENOTYPE; HAND FOOT AND MOUTH DISEASE; HUMAN; MOLECULAR DIAGNOSIS; NEUROLOGIC DISEASE; POLIOMYELITIS VIRUS; RESPIRATORY TRACT DISEASE; REVIEW; SEROTYPE; SKIN DISEASE; TROPISM; UNITED STATES; ENTEROVIRUS; EPIDEMIOLOGY;

DISEASE OUTBREAKS; ENTEROVIRUS; ENTEROVIRUS INFECTIONS; HAND, FOOT AND MOUTH DISEASE; HUMANS; UNITED STATES;

EID: 84954412058     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0000000000000187     Document Type: Review

References (96)

1. Oberste MS, Maher K, Kilpatrick DR, et al. Molecular evolution of the human enteroviruses: correlation of serotype with VP1 sequence and application to picornavirus classification. J Virol. 1999; 73: 1941-1948.
2. Pallansch MA, Oberste MS, Whitton JL. Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses. In Knipe DM, Howley P, editors. Fields virology 2. 6th ed. Lippincott Williams &Wilkins; 2013.
3. Rao CD, Yergolkar P, Shankarappa KS. Antigenic diversity of enteroviruses associated with nonpolio acute flaccid paralysis, India, 2007-2009. Emerg Infect Dis. 2012; 18: 1833-1840.
4. Khetsuriani N, Lamonte-Fowlkes A, Oberste S, et al. Enterovirus surveillance: United States, 1970-2005. Morb Mortal Wkly Rep Surveill Summ. 2006; 55: 1-20.
5. Antona D, Leveque N, Chomel JJ, et al. Surveillance of enteroviruses in France, 2000-2004. Eur J Clin Microbiol Infect Dis. 2007; 26: 403-412.
6. Kadambari S, Bukasa A, Okike IO, et al. Enterovirus infections in England and Wales, 2000-2011: the impact of increased molecular diagnostics. Clin Microbiol Infect. 2014; 20: 1289-1296.
7. van der Sanden SM, Koopmans MP, van der Avoort HG. Detection of human enteroviruses and parechoviruses as part of the national enterovirus surveillance in the Netherlands, 1996-2011. Eur J Clin Microbiol Infect Dis. 2013; 32: 1525-1531.
8. CDC. Enterovirus D68. 2015. http://www.cdc.gov/nonpolio-enterovirus/.about/ev-d68.html. [Accessed 31 May 2015
9. Midgley CM, Jackson MA, Selvarangan R, et al. Severe respiratory illness associated with enterovirus D68: Missouri and Illinois, 2014. MMWR Morb Mortal Wkly Rep. 2014; 63: 798-799.
10. Oberste MS, Maher K, Schnurr D, et al. Enterovirus 68 is associated with respiratory illness and shares biological features with both the enteroviruses and the rhinoviruses. J Gen Virol. 2004; 85: 2577-2584.
11. Schieble JH, Fox VL, Lennette EH. A probable new human picornavirus associated with respiratory diseases. Am J Epidemiol. 1967; 85: 297-310.
12. CDC. Clusters of acute respiratory illness associated with human enterovirus 68: Asia, Europe, and United States, 2008-2010. MMWR Morb Mortal Wkly Rep. 2011; 60: 1301-1304.
13. Ikeda T, Mizuta K, Abiko C, et al. Acute respiratory infections due to enterovirus 68 in Yamagata, Japan between 2005 and 2010. Microbiol Immunol. 2012; 56: 139-143.
14. Imamura T, Fuji N, Suzuki A, et al. Enterovirus 68 among children with severe acute respiratory infection, the Philippines. Emerg Infect Dis. 2011; 17: 1430-1435.
15. Kaida A, Kubo H, Sekiguchi J, et al. Enterovirus 68 in children with acute respiratory tract infections, Osaka, Japan. Emerg Infect Dis. 2011; 17: 1494-1497.
16. Meijer A, van der Sanden S, Snijders BE, et al. Emergence and epidemic occurrence of enterovirus 68 respiratory infections in The Netherlands in 2010. Virology. 2012; 423: 49-57.
17. Piralla A, Baldanti F, Gerna G. Phylogenetic patterns of human respiratory picornavirus species, including the newly identified group C rhinoviruses, during a 1year surveillance of a hospitalized patient population in Italy. J Clin Microbiol. 2011; 49: 373-376.
18. Tokarz R, Kapoor V, Wu W, et al. Longitudinal molecular microbial analysis of influenza-like illness in New York City, May 2009 through May 2010. Virol J. 2011; 8: 288.
19. Tokarz R, Firth C, Madhi SA, et al. Worldwide emergence of multiple clades of enterovirus 68. J Gen Virol. 2012; 93: 1952-1958.
20. Imamura T, Okamoto M, Nakakita S, et al. Antigenic and receptor binding properties of enterovirus 68. J Virol. 2014; 88: 2374-2384.
21. CDC. Summary of findings: investigation of acute flaccid myelitis in U.S. children, 2014-15. 2014. http://www.cdc.gov/ncird/investigation/viral/.2014-15/investigation.html. [Accessed 31 May 2014
22. Messacar K, Schreiner TL, Maloney JA, et al. A cluster of acute flaccid paralysis and cranial nerve dysfunction temporally associated with an outbreak of enterovirus D68 in children in Colorado, USA. Lancet. 2015; 385: 1662-1671.
23. Pastula DM, Aliabadi N, Haynes AK, et al. Acute neurologic illness of unknown etiology in children: Colorado, August-September 2014.MMWRMorb Mortal Wkly Rep. 2014; 63: 901-902.
24. CDC. Notes from the field: acute flaccid myelitis among persons aged /21 years: United States, August 1-November 13, 2014 MMWR Morb Mortal Wkly Rep 2015 63 1243-1244.
25. Ayscue P, Van Haren K, Sheriff H, et al. Acute flaccid paralysis with anterior myelitis: California, June 2012-June 2014. MMWR Morb Mortal Wkly Rep. 2014; 63: 903-906.
26. Kreuter JD, Barnes A, McCarthy JE, et al. A fatal central nervous system enterovirus 68 infection. Arch Pathol Lab Med. 2011; 135: 793-796.
27. Greninger AL, Naccache SN, Messacar K, et al. A novel outbreak enterovirus D68 strain associated with acute flaccid myelitis cases in the USA (2012-14): a retrospective cohort study. Lancet Infect Dis. 2015; 15: 671-682.
28. Fonseca MC, Sarmiento L, Resik S, et al. Isolation of coxsackievirus A24 variant from patients with hemorrhagic conjunctivitis in Cuba, 2008-2009. J Clin Virol. 2012; 53: 77-81.
29. Kono R, Miyamura K, Tajiri E, et al. Virological and serological studies of neurological complications of acute hemorrhagic conjunctivitis in Thailand. J Infect Dis. 1977; 135: 706-713.
30. Nilsson EC, Jamshidi F, Johansson SM, et al. Sialic acid is a cellular receptor for coxsackievirus A24 variant, an emerging virus with pandemic potential. J Virol. 2008; 82: 3061-3068.
31. Wadia NH, Wadia PN, Katrak SM, et al. A study of the neurological disorder associated with acute haemorrhagic conjunctivitis due to enterovirus 70. J Neurol Neurosurg Psychiatry. 1983; 46: 599-610.
32. Chatterjee S, Quarcoopome CO, Apenteng A. Unusual type of epidemic conjunctivitis in Ghana. Br J Ophthalmol. 1970; 54: 628-630.
33. Mirkovic RR, Kono R, Yin-Murphy M, et al. Enterovirus type 70: the etiologic agent of pandemic acute haemorrhagic conjunctivitis. Bull World Health Organ. 1973; 49: 341-346.
34. Kono R. Apollo 11 disease or acute hemorrhagic conjunctivitis: a pandemic of a new enterovirus infection of the eyes. Am J Epidemiol. 1975; 101: 383-390.
35. Maitreyi RS, Dar L, Muthukumar A, et al. Acute hemorrhagic conjunctivitis due to enterovirus 70 in India. Emerg Infect Dis. 1999; 5: 267-269.
36. Shulman LM, Manor Y, Azar R, et al. Identification of a new strain of fastidious enterovirus 70 as the causative agent of an outbreak of hemorrhagic conjunctivitis. J Clin Microbiol. 1997; 35: 2145-2149.
37. Uchio E, Yamazaki K, Ishikawa H, et al. An epidemic of acute haemorrhagic conjunctivitis caused by enterovirus 70 in Okinawa, Japan, in 1994. Graefes Arch Clin Exp Ophthalmol. 1999; 237: 568-572.
38. Mirkovic RR, Schmidt NJ, Yin-Murphy M, et al. Enterovirus etiology of the 1970 Singapore epidemic of acute conjunctivitis. Intervirology. 1974; 4: 119-127.
39. Wu B, Qi X, Xu K, et al. Genetic characteristics of the coxsackievirus A24 variant causing outbreaks of acute hemorrhagic conjunctivitis in Jiangsu, China, 2010. PLoS One. 2014; 9: e86883.
40. Shukla D, Kumar A, Srivastava S, et al. Molecular identification and phylogenetic study of coxsackievirus A24 variant isolated from an outbreak of acute hemorrhagic conjunctivitis in India in 2010. Arch Virol. 2013; 158: 679-684.
41. Nidaira M, Kuba Y, Saitoh M, et al. Molecular evolution of VP3, VP1, 3C(pro) and 3D(pol) coding regions in coxsackievirus group A type 24 variant isolates from acute hemorrhagic conjunctivitis in 2011 in Okinawa, Japan. Microbiol Immunol. 2014; 58: 227-238.
42. Chansaenroj J, Vongpunsawad S, Puenpa J, et al. Epidemic outbreak of acute haemorrhagic conjunctivitis caused by coxsackievirus A24 in Thailand, 2014. Epidemiol Infect. 2015; 1-7.
43. Lin KH, Wang HL, Sheu MM, et al. Molecular epidemiology of a variant of coxsackievirus A24 in Taiwan: two epidemics caused by phylogenetically distinct viruses from 1985 to 1989. J Clin Microbiol. 1993; 31: 1160-1166.
44. Miyamura K, Yamashita K, Takeda N, et al. The first epidemic of acute hemorrhagic conjunctivitis due to a coxsackievirus A24 variant in Okinawa, Japan, in 1985-1986. Jpn J Med Sci Biol. 1988; 41: 159-174.
45. Oh MD, Park S, Choi Y, et al. Acute hemorrhagic conjunctivitis caused by coxsackievirus A24 variant, South Korea, 2002. Emerg Infect Dis. 2003; 9: 1010-1012.
46. Ayoub EA, Shafik CF, Gaynor AM, et al. A molecular investigative approach to an outbreak of acute hemorrhagic conjunctivitis in Egypt, October 2010. Virol J. 2013; 10: 96.
47. Tavares FN, Campos Rde M, Burlandy FM, et al. Molecular characterization and phylogenetic study of coxsackievirus A24 v causing outbreaks of acute hemorrhagic conjunctivitis (AHC) in Brazil. PLoS One. 2011; 6: e23206.
48. Aoki K, Sawada H. Long-Term observation of neutralization antibody after enterovirus 70 infection. Jpn J Ophthalmol. 1992; 36: 465-468.
49. Goh KT, Ooi PL, Miyamura K, et al. Acute haemorrhagic conjunctivitis: seroepidemiology of coxsackievirus A24 variant and enterovirus 70 in Singapore. J Med Virol. 1990; 31: 245-247.
50. Finger C. Brazil faces worst outbreak of conjunctivitis in 20 years. Lancet. 2003; 361: 1714.
51. Chang LY, Lin TY, Huang YC, et al. Comparison of enterovirus 71 and coxsackie-virus A16 clinical illnesses during the Taiwan enterovirus epidemic, 1998. Pediatr Infect Dis J. 1999; 18: 1092-1096.
52. Ooi MH, Wong SC, Podin Y, et al. Human enterovirus 71 disease in Sarawak, Malaysia: a prospective clinical, virological, and molecular epidemiological study. Clin Infect Dis. 2007; 44: 646-656.
53. Ooi MH, Wong SC, Lewthwaite P, et al. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol. 2010; 9: 1097-1105.
54. Solomon T, Lewthwaite P, Perera D, et al. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis. 2010; 10: 778-790.
55. Yamayoshi S, Fujii K, Koike S. Receptors for enterovirus 71. Emerg Microbes Infect. 2014; 3: e53.
56. Shindarov LM, Chumakov MP, Voroshilova MK, et al. Epidemiological, clinical, and pathomorphological characteristics of epidemic poliomyelitis-like disease caused by enterovirus 71. J Hyg Epidemiol Microbiol Immunol. 1979; 23: 284-295.
57. Nagy G, Takatsy S, Kukan E, et al. Virological diagnosis of enterovirus type 71 infections: experiences gained during an epidemic of acute CNS diseases in Hungary in 1978. Arch Virol. 1982; 71: 217-227.
58. WHO. A guide to clinical management and public health response for hand, foot and mouth disease (HFMD). Geneva: WHO; 2011.
59. Cardosa MJ, Krishnan S, Tio PH, et al. Isolation of subgenus B adenovirus during a fatal outbreak of enterovirus 71-Associated hand, foot, and mouth disease in Sibu, Sarawak. Lancet. 1999; 354: 987-991.
60. CDC. Deaths among children during an outbreak of hand, foot, and mouth disease: Taiwan, Republic of China, April-July 1998. MMWR Morb Mortal Wkly Rep. 1998; 47: 629-632.
61. Ho M, Chen ER, Hsu KH, et al. An epidemic of enterovirus 71 infection in Taiwan. N Engl J Med. 1999; 341: 929-935.
62. Liu SL, Pan H, Liu P, et al. Comparative epidemiology and virology of fatal and nonfatal cases of hand, foot and mouth disease in mainland China from 2008 to 2014. Rev Med Virol. 2015; 25: 115-128.
63. Xing W, Liao Q, Viboud C, et al. Hand, foot, and mouth disease in China, 2008-12: an epidemiological study. Lancet Infect Dis. 2014; 14: 308-318.
64. NIID. Hand, foot and mouth disease in Japan, 2002-2011. IASR. 2012; 33: 55-56.
65. Tu PV, Thao NT, Perera D, et al. Epidemiologic and virologic investigation of hand, foot, and mouth disease, southern Vietnam, 2005. Emerg Infect Dis. 2007; 13: 1733-1741.
66. Ang LW, Tay J, Phoon MC, et al. Seroepidemiology of coxsackievirus A6, coxsackievirus A16, and enterovirus 71 infections among children and adolescents in Singapore, 2008-2010. PLoS One. 2015; 10: e0127999.
67. Singapore Ministry of Health. Communicable Disease Surveillance Annual Report. Singapore: Ministry of Health; 2013.
68. Singapore Ministry of Health. Communicable Disease Surveillance Annual Report. Singapore: Ministry of Health; 2014.
69. Ma E, Chan KC, Cheng P, et al. The enterovirus 71 epidemic in 2008: public health implications for Hong Kong. Int J Infect Dis. 2010; 14: e775-e780.
70. Podin Y, Gias EL, Ong F, et al. Sentinel surveillance for human enterovirus 71 in Sarawak, Malaysia: lessons from the first 7 years. BMC Public Health. 2006; 6: 180.
71. Di B, Zhang Y, Xie H, et al. Circulation of coxsackievirus A6 in hand-foot-Andmouth disease in Guangzhou, 2010-2012. Virol J. 2014; 11: 157.
72. He YQ, Chen L, Xu WB, et al. Emergence, circulation, and spatiotemporal phylogenetic analysis of coxsackievirus A6- And coxsackievirus A10-Associated hand, foot, and mouth disease infections from 2008 to 2012 in Shenzhen, China. J Clin Microbiol. 2013; 51: 3560-3566.
73. Hongyan G, Chengjie M, Qiaozhi Y, et al. Hand, foot and mouth disease caused by coxsackievirus A6, Beijing. Pediatr Infect Dis J. 2014; 33: 1302-1303.
74. Huang Y, Zhou Y, Lu H, et al. Characterization of severe hand, foot, and mouth disease in Shenzhen, China. J Med Virol 2015. [Epub ahead of print
75. Tan X, Li L, Zhang B, et al. Molecular epidemiology of coxsackievirus A6 associated with outbreaks of hand, foot, and mouth disease in Tianjin, China, in. Arch Virol. 2015; 160: 1097-1104.
76. Zeng H, Lu J, Zheng H, et al. The epidemiological study of coxsackievirus A6 revealing hand, foot and mouth disease epidemic patterns in Guangdong, China. Sci Rep. 2015; 5: 10550.
77. Yang Q, Ding J, Cao J, et al. Epidemiological and etiological characteristics of hand, foot, and mouth disease in Wuhan, China from 2012 to 2013: outbreaks of coxsackieviruses A10. J Med Virol. 2015; 87: 954-960.
78. Zhang C, Zhu R, Yang Y, et al. Phylogenetic analysis of the major causative agents of hand, foot and mouth disease in Suzhou city, Jiangsu province, China, in 2012-2013. Emerg Microbes Infect. 2015; 4: e12.
79. Bracho MA, Gonzalez-Candelas F, Valero A, et al. Enterovirus co-infections and onychomadesis after hand, foot, and mouth disease, Spain. Emerg Infect Dis. 2011; 17: 2223-2231.
80. Osterback R, Vuorinen T, Linna M, et al. Coxsackievirus A6 and hand, foot, and mouth disease, Finland. Emerg Infect Dis. 2009; 15: 1485-1488.
81. Sarma N. Hand, foot, and mouth disease: current scenario and Indian perspective. Indian J Dermatol Venereol Leprol. 2013; 79: 165-175.
82. Ong KC, Devi S, Cardosa MJ, et al. Formaldehyde-inactivated whole-virus vaccine protects a murine model of enterovirus 71 encephalomyelitis against disease. J Virol. 2010; 84: 661-665.
83. Arita M, Nagata N, Iwata N, et al. An attenuated strain of enterovirus 71 belonging to genotype a showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys. J Virol. 2007; 81: 9386-9395.
84. Li HY, Han JF, Qin CF, et al. Virus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in mice. Vaccine. 2013; 31: 3281-3287.
85. Wu CN, Lin YC, Fann C, et al. Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. Vaccine. 2001; 20: 895-904.
86. Li JX, Mao QY, Liang ZL, et al. Development of enterovirus 71 vaccines: from the lab bench to Phase III clinical trials. Expert Rev Vaccines. 2014; 13: 609-618.
87. Li R, Liu L, Mo Z, et al. An inactivated enterovirus 71 vaccine in healthy children. N Engl J Med. 2014; 370: 829-837.
88. Zhu F, Xu W, Xia J, et al. Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China. N Engl J Med. 2014; 370: 818-828.
89. Zhu FC, Meng FY, Li JX, et al. Efficacy, safety, and immunology of an inactivated alum-Adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2013; 381: 2024-2032.
90. Mao Q, Cheng T, Zhu F, et al. The cross-neutralizing activity of enterovirus 71 subgenotype C4 vaccines in healthy Chinese infants and children. PLoS One. 2013; 8: e79599.
91. Chou AH, Liu CC, Chang JY, et al. Formalin-inactivated EV71 vaccine candidate induced cross-neutralizing antibody against subgenotypes B1, B4, B5 and C4A in adult volunteers. PLoS One. 2013; 8: e79783.
92. Cai Y, Ku Z, Liu Q, et al. A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses. Vaccine. 2014; 32: 2406-2412.
93. Henquell C, Mirand A, Richter J, et al. Phylogenetic patterns of human coxsackievirus B5 arise from population dynamics between two genogroups and reveal evolutionary factors of molecular adaptation and transmission. J Virol. 2013; 87: 12249-12259.
94. McWilliam Leitch EC, Cabrerizo M, Cardosa J, et al. Evolutionary dynamics and temporal/geographical correlates of recombination in the human enterovirus echovirus types 9, 11, and 30. J Virol. 2010; 84: 9292-9300.
95. Cabrerizo M, Trallero G, Simmonds P. Recombination and evolutionary dynamics of human echovirus 6. J Med Virol. 2014; 86: 857-864.
96. Huang SW, Hsu YW, Smith DJ, et al. Reemergence of enterovirus 71 in 2008 in Taiwan: dynamics of genetic and antigenic evolution from 1998 to 2008. J Clin Microbiol. 2009; 47: 3653-3662.